Disadvantages of set length antibiotic treatment for pulmonary exacerbation

Disadvantages of set length antibiotic treatment for pulmonary exacerbation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet respiratory medicine 2018-08, Vol.6 (8), p.573-575
1. Verfasser: Stephen, Michael J
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Bacterial Agents
Humans
Lung
Pulmonary Disease, Chronic Obstructive
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 575
container_issue 8
container_start_page 573
container_title The lancet respiratory medicine
container_volume 6
creator Stephen, Michael J
description
doi_str_mv 10.1016/S2213-2600(18)30266-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2063730688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213260018302662</els_id><sourcerecordid>2063730688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-f659a0f6369e2eb0e425bd58c0272423e6ecec6412e3f9e71b6eaca37e05b5293</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EolXpI4B8LIeAl8RJTgiVVVTiAJwtx5kUoyQutlPB2-MucGUus-if7UPolJILSqi4fGGM8oQJQma0OOeECZGwAzTel2l5-BcTMkJT7z9ItKJIGUmP0YiVpYgZHaOnG-NVvVZ9UEvw2DbYQ8At9MvwjmPVVMYGo3FwoEIHfcCNdXg1tJ3tlfvG8KU0uEoFY_sTdNSo1sN07yfo7e72df6QLJ7vH-fXi0RzkYWkEVmpSCO4KIFBRSBlWVVnhSYsZynjIECDFillwJsScloJUFrxHEhWZazkEzTbzV05-zmAD7IzXkPbqh7s4CUjgueciKKI0mwn1c5676CRK2e6eLikRG5Qyi1KueEkaSG3KCWLfWf7FUPVQf3X9QsuCq52AoiPrg046bWBXkNtHOgga2v-WfEDko-DaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2063730688</pqid></control><display><type>article</type><title>Disadvantages of set length antibiotic treatment for pulmonary exacerbation</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Stephen, Michael J</creator><creatorcontrib>Stephen, Michael J</creatorcontrib><identifier>ISSN: 2213-2600</identifier><identifier>EISSN: 2213-2619</identifier><identifier>DOI: 10.1016/S2213-2600(18)30266-2</identifier><identifier>PMID: 29960881</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents ; Humans ; Lung ; Pulmonary Disease, Chronic Obstructive</subject><ispartof>The lancet respiratory medicine, 2018-08, Vol.6 (8), p.573-575</ispartof><rights>2018 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-f659a0f6369e2eb0e425bd58c0272423e6ecec6412e3f9e71b6eaca37e05b5293</citedby><cites>FETCH-LOGICAL-c365t-f659a0f6369e2eb0e425bd58c0272423e6ecec6412e3f9e71b6eaca37e05b5293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29960881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stephen, Michael J</creatorcontrib><title>Disadvantages of set length antibiotic treatment for pulmonary exacerbation</title><title>The lancet respiratory medicine</title><addtitle>Lancet Respir Med</addtitle><subject>Anti-Bacterial Agents</subject><subject>Humans</subject><subject>Lung</subject><subject>Pulmonary Disease, Chronic Obstructive</subject><issn>2213-2600</issn><issn>2213-2619</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAQhi0EolXpI4B8LIeAl8RJTgiVVVTiAJwtx5kUoyQutlPB2-MucGUus-if7UPolJILSqi4fGGM8oQJQma0OOeECZGwAzTel2l5-BcTMkJT7z9ItKJIGUmP0YiVpYgZHaOnG-NVvVZ9UEvw2DbYQ8At9MvwjmPVVMYGo3FwoEIHfcCNdXg1tJ3tlfvG8KU0uEoFY_sTdNSo1sN07yfo7e72df6QLJ7vH-fXi0RzkYWkEVmpSCO4KIFBRSBlWVVnhSYsZynjIECDFillwJsScloJUFrxHEhWZazkEzTbzV05-zmAD7IzXkPbqh7s4CUjgueciKKI0mwn1c5676CRK2e6eLikRG5Qyi1KueEkaSG3KCWLfWf7FUPVQf3X9QsuCq52AoiPrg046bWBXkNtHOgga2v-WfEDko-DaQ</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Stephen, Michael J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201808</creationdate><title>Disadvantages of set length antibiotic treatment for pulmonary exacerbation</title><author>Stephen, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-f659a0f6369e2eb0e425bd58c0272423e6ecec6412e3f9e71b6eaca37e05b5293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-Bacterial Agents</topic><topic>Humans</topic><topic>Lung</topic><topic>Pulmonary Disease, Chronic Obstructive</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stephen, Michael J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stephen, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disadvantages of set length antibiotic treatment for pulmonary exacerbation</atitle><jtitle>The lancet respiratory medicine</jtitle><addtitle>Lancet Respir Med</addtitle><date>2018-08</date><risdate>2018</risdate><volume>6</volume><issue>8</issue><spage>573</spage><epage>575</epage><pages>573-575</pages><issn>2213-2600</issn><eissn>2213-2619</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29960881</pmid><doi>10.1016/S2213-2600(18)30266-2</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2213-2600
ispartof The lancet respiratory medicine, 2018-08, Vol.6 (8), p.573-575
issn 2213-2600
2213-2619
language eng
recordid cdi_proquest_miscellaneous_2063730688
source MEDLINE; Alma/SFX Local Collection
subjects Anti-Bacterial Agents
Humans
Lung
Pulmonary Disease, Chronic Obstructive
title Disadvantages of set length antibiotic treatment for pulmonary exacerbation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A29%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disadvantages%20of%20set%20length%20antibiotic%20treatment%20for%20pulmonary%20exacerbation&rft.jtitle=The%20lancet%20respiratory%20medicine&rft.au=Stephen,%20Michael%20J&rft.date=2018-08&rft.volume=6&rft.issue=8&rft.spage=573&rft.epage=575&rft.pages=573-575&rft.issn=2213-2600&rft.eissn=2213-2619&rft_id=info:doi/10.1016/S2213-2600(18)30266-2&rft_dat=%3Cproquest_cross%3E2063730688%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2063730688&rft_id=info:pmid/29960881&rft_els_id=S2213260018302662&rfr_iscdi=true